For citations:
Volkova M.I., Olshanskaya A.S., Kalinin S.A. Efficacy and safety of adjuvant therapy with nivolumab or placebo in high-risk patients with muscle-invasive urothelial carcinoma after radical surgery: review of the first results of the randomized phase III trial CheckMate 274. Cancer Urology. 2021;17(1):108-119. (In Russ.) https://doi.org/10.17650/1726-9776-2021-17-1-108-119
Email this article 